NCT04084626 2022-01-05PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBVBeijing Friendship HospitalPhase 3 Unknown40 enrolled
NCT02912702 2016-09-23L-DEP as an Initial Treatment for EBV-HLHBeijing Friendship HospitalPhase 3 Unknown120 enrolled
NCT02631109 2016-08-04L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic LymphohistiocytosisBeijing Friendship HospitalPhase 3 Unknown120 enrolled